Search clinical trials for: NovoFine® vs Nucleus

Total 340 results

Becton, Dickinson and Company

Completed

Evaluating the User Performance and Experience of Nucleus Pen vs. Commercially Available Pen Needle

Diabetes

United States
Novo Nordisk A/S

Completed

Comparison of NovoFine® Needles (4 mm vs. 6 mm)

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | Delivery Systems

Denmark
Novo Nordisk A/S

Completed

Comparison of 2 NovoFine® Needles on the Reflux of Insulin

Diabetes | Diabetes Mellitus, Type 1 | Delivery Systems

Italy
Novo Nordisk A/S

Completed

Localisation of Potential Insulin Deposits in Normal Weight and Obese Diabetics Using 6 mm and 12 mm Long Needles

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | Delivery Systems

Denmark
Novo Nordisk A/S

Completed

Evaluating the Use of Two Different Needles in Subjects With Diabetes

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | Delivery Systems

United Kingdom
Novo Nordisk A/S

Completed

Preference Study Between NovoFine® Autocover™ and a NovoFine® 8 mm Needle

Diabetes | Delivery Systems | Healthcare Professionals

Denmark
Novo Nordisk A/S

Completed

Comparison of Glycemic Control Achieved With 2 Different Needles

Diabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1 | Delivery Systems

United States
National Taiwan University Hospital
Ministry of Science and Technology, Taiwan; Teleflex

Completed

Venous Injection Compared To intraOsseous Injection During Resuscitation of Patients With Out-of-hospital Cardiac Arrest (VICTOR)

Vascular Access | Out-of-Hospital Cardiac Arrest | Intraosseous Access | Emergency Medical Service | Intravenous Access

Taiwan
Charite University, Berlin, Germany
German Federal Ministry of Education and Research

Terminated

Mesh Ablator Versus Cryoballoon Pulmonary Vein Ablation of Symptomatic Paroxysmal Atrial Fibrillation (MACPAF)

Symptomatic Paroxysmal Atrial Fibrillation

Germany
Seung-Jung Park
CardioVascular Research Foundation, Korea

Withdrawn

Star-Close Versus Angio-Seal for Femoral Artery Hemostasis (CLOSE)

Percutaneous Intervention Via Femoral Artery

Korea, Republic of
Empros Pharma AB
CTC Clinical Trial Consultants AB

Recruiting

A Phase 1 Study to Evaluate EMP22 PD and EMP16 PK Versus Xenical® in Healthy Volunteers

Overweight or Obesity

Sweden
Wockhardt

Terminated

Immunosafety Study of Recombinant Human Insulins in Type 1 Diabetics

Type I Diabetes

United States, India
Bruce J Gantz

Completed

Hybrid Cochlear Implants in Severe to Profound Adults, Children, and Adolescents

Hearing Loss, High-Frequency

United States
Cochlear
NAMSA; LWB Consulting

Not yet recruiting

Safety and Effectiveness of Cochlear Implantation in an Expanded Adult Population (ACE)

Hearing Loss, Sensorineural | Hearing Loss, Bilateral

United States
Spinal Stabilization Technologies

Active, not recruiting

Safety Study for An Artificial Disc Replacement to Treat Chronic Low Back Pain

Chronic Low-back Pain | Degenerative Disc Disease

Canada, Croatia, Belgium, Germany
Verastem, Inc.
Mirati Therapeutics Inc.

Recruiting

Study of Avutometinib (VS-6766) + Adagrasib in KRAS G12C NSCLC Patients (RAMP204)

Non Small Cell Lung Cancer | Metastatic Cancer | Advanced Cancer | Malignant Neoplasm of Lung | Malignant Neoplastic Disease | KRAS Activating Mutation

United States
Cochlear
NAMSA

Recruiting

Investigation to Evaluate the Safety and Effectiveness of Cochlear Implantation in Children and Adults With Unilateral Hearing Loss/Single-sided Deafness (PAS-SSD)

Hearing Loss, Unilateral | Deafness, Unilateral

United States
McMaster University
Canadian Institutes of Health Research (CIHR); Boehringer Ingelheim; Medtronic; Heart and Stroke Foundation of Canada

Completed

Telmisartan-Induced Reduction in Intra-Myocellular Lipids Trial

Metabolic Syndrome X

Canada
Novo Nordisk A/S

Completed

Comparison of Human Insulin to Insulin Inhalation Solution in Children With Type 1 Diabetes

Diabetes | Diabetes Mellitus, Type 1

Denmark
Watson Pharmaceuticals
Massachusetts General Hospital

Completed

A Comparison of Patch vs. Pill Estrogen Therapy on Testosterone Levels and Thyroid Tests in Menopausal Women

Menopause

United States
Sanofi

Withdrawn

A Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Single Dose of SAR438544 in Comparison to Glucagon in Type 1 Diabetes Mellitus Patients Under Induced Hypoglycemia

Type 1 Diabetes Mellitus
University Ghent

Withdrawn

Hemostatic Gelatin Sponge Versus Collagen Matrix in Alveolar Ridge Preservation

Changes in Soft Tissue Height

Belgium
Spinal Stabilization Technologies

Active, not recruiting

Lumbar Operatively Inserted PerQdisc Artificial Implant Following Nuclectomy (LOPAIN1)

Chronic Low-back Pain | Degenerative Disc Disease

Paraguay
Sanofi

Completed

Assessment of Efficacy and Safety of Insuman Comb 25 Versus Novolin® 30R Twice Daily Over 24 Weeks in Type 2 Diabetes Patients With Insulin Therapy (Insuman-C25-CN)

Type 2 Diabetes Mellitus

China
Kremers Urban Development Company
Watson Laboratories, Inc.

Completed

Bioequivalence Study of Bicalutamide 50 mg Tablet and Casodex 50 mg Tablet in Healthy Subjects Under Fasting Conditions

Bioequivalency

Canada
Oregon Health and Science University

Unknown

Prophylactic Therapy for Cytomegalovirus in Liver Transplant Recipients

Liver Transplantation
Federal University of São Paulo

Completed

Customized PRK With Mitomycin Versus Customized Lasik for Myopic Astigmatism

Refractive Errors
Eurofarma Laboratorios S.A.

Completed

Efficacy and Safety Study of Glucosamine/Chondroitin Sulfate to Patients Treatment With Osteoarthrosis of the Knee (Artico)

Osteoarthritis of the Knee

Brazil
Universitaire Ziekenhuizen KU Leuven

Recruiting

Nodular Shrinking in Dupuytren Disease (Echo)

Dupuytren's Disease

Belgium
Fondazione I.R.C.C.S. Istituto Neurologico Carlo...
Ministry of Health, Italy

Completed

Subthalamic Stimulation in Tourette's Syndrome (STN-DBSinTS)

Tourette Syndrome | Tourette's Syndrome | Tourette Disorder | Gilles de la Tourette Syndrome

Italy
Hoffmann-La Roche
Roche Molecular Systems, Inc

Not yet recruiting

A Study of the Cobas® Liat CT/NG/MG Test Versus Current Standard Practice for Managing Participants at Increased Risk of Sexually Transmitted Infections

Chlamydia Trachomatis Infection | Mycoplasma Genitalium Infection | Neisseria Gonorrhoeae Infection
Incyte Corporation

Terminated

Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer

NSCLC (Non-small Cell Lung Carcinoma)

United States
Novartis Pharmaceuticals
Merck Sharp & Dohme LLC

Completed

Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies

Chronic Hepatitis B

United States, Australia, Canada, China, Czechia, France, Germany, Hong Kong, India, Israel, Italy, Korea, Republic of, New Zealand, Poland, Puerto Rico, Singapore, Spain, Taiwan, Thailand, Turkey, United Kingdom
Gilead Sciences

Completed

Switching From a Tenofovir Disoproxil Fumarate (TDF) Containing Regimen to Elvitegravir/Cobicistat/Emtricitabine/ Tenofovir Alafenamide (E/C/F/TAF) Fixed-Dose Combination (FDC) in Virologically-Suppressed, HIV-1 Infected Adults Aged ≥ 60 Years

HIV-1 Infection

Spain, United Kingdom, Italy, France, Belgium
Merck Sharp & Dohme LLC

Active, not recruiting

Study of Pembrolizumab With Maintenance Olaparib or Maintenance Pemetrexed in First-line (1L) Metastatic Nonsquamous Non-Small-Cell Lung Cancer (NSCLC) (MK-7339-006, KEYLYNK-006)

Carcinoma, Non-squamous Non-small-cell Lung

Poland, Korea, Republic of, Ukraine, United States, Argentina, Australia, Austria, Canada, France, Japan, New Zealand, Romania, Russian Federation, Taiwan, Turkey, United Kingdom, Brazil, Colombia, Germany, Spain
Ochsner Health System
Astellas Pharma Global Development, Inc.

Completed

Intravenous Regadenoson Versus Intravenous Adenoscan® for Fractional Flow Reserve (FFR)

Coronary Artery Disease

United States
Merck Sharp & Dohme LLC

Active, not recruiting

Study of Pembrolizumab/Vibostolimab Coformulation (MK-7684A) in Combination With Chemotherapy Versus Pembrolizumab Plus Chemotherapy in Participants With Metastatic Non-Small Cell Lung Cancer (MK-7684A-007/KEYVIBE-007)

Metastatic Non-Small Cell Lung Cancer

Poland, United States, Argentina, Austria, Brazil, Chile, China, Colombia, France, Germany, Israel, Japan, Korea, Republic of, Mexico, Spain, Taiwan, Thailand, Turkey, United Kingdom
Merck Sharp & Dohme LLC

Active, not recruiting

Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)

Non-small Cell Lung Cancer

United States, Argentina, Australia, Belgium, Brazil, Canada, China, Estonia, France, Germany, Ireland, Italy, Japan, Korea, Republic of, Latvia, Lithuania, Malaysia, Poland, Romania, Russian Federation, South Africa, Spain, Taiwan, U... and more
Nektar Therapeutics

Terminated

Bempegaldesleukin and Pembrolizumab With or Without Chemotherapy in Locally Advanced or Metastatic Solid Tumors (PROPEL)

Non-Small Cell Lung Cancer

United States, Germany, Spain, Australia, France
AIO-Studien-gGmbH
Boehringer Ingelheim

Terminated

Maintaining ERBB Blockade in EGFR-mutated Lung Cancer (MARBLE)

Non-small-cell Lung Cancer With Somatic EGFR Mutations

Germany
Universitair Ziekenhuis Brussel

Completed

SHorter Treatment of Replacement Therapy for Frozen Embryo Transfer (FET) (ShoRT)

Infertility

Belgium
Gilead Sciences

Terminated

Study to Evaluate the Efficacy of GS-9131 Functional Monotherapy in Human Immunodeficiency Virus (HIV)-1-Infected Adults Failing a Nucleos(t)Ide Reverse Transcriptase Inhibitor-Containing Regimen With Nucleos(t)Ide Reverse Transcriptase Inhibitor Resistant Virus

HIV-1-infection

Uganda, Zimbabwe
Procter and Gamble

Completed

A Pilot Clinical Study to Evaluate the Safety and Efficacy of Marketed Oxalate Strips Compared to a Marketed Safety Pen

Dentin Sensitivity

United States
Korea University
GlaxoSmithKline

Completed

Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis B

Chronic Hepatitis B

Korea, Republic of
Novartis Pharmaceuticals

Completed

Study of Imatinib Mesylate in Combination With Hydroxyurea Versus Hydroxyurea Alone as an Oral Therapy in Patients With Temozolomide Resistant Progressive Glioblastoma

Astrocytoma | Glioblastoma Multiforme

Germany
Merck Sharp & Dohme LLC

Active, not recruiting

Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

Carcinoma, Non-Small-Cell Lung | Lung Neoplasms

Poland, Romania, Ukraine, Chile, Canada, United States, Argentina, China, Czechia, Estonia, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Latvia, Lithuania, Mexico, Norway, Peru, Russian Federation, Spain, Thailand, Turkey, United...
Julia K. Rotow, MD
Inivata

Active, not recruiting

Plasma-Adapted First-Line Pembro In NSCLC

Metastatic Non-Small Cell Lung Cancer | NSCLC Stage IV

United States
St. Jude Children's Research Hospital

Completed

Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma

Lymphoblastic Lymphoma

United States
Salvador Gil-Vernet
Roche Pharma AG

Completed

Valganciclovir for Treatment of Cytomegalovirus Infection in Solid Organ Transplant Patients

Cytomegalovirus Infection

Spain
Hoffmann-La Roche

Completed

Alectinib Versus Pemetrexed or Docetaxel in Anaplastic Lymphoma Kinase (ALK)-Positive Advanced Non-Small Cell Lung Cancer (NSCLC) Participants Previously Treated With Platinum-Based Chemotherapy and Crizotinib

Non-small Cell Lung Cancer

Belgium, Italy, Portugal, Spain, Germany, Turkey, France, Hong Kong, Korea, Republic of, Poland, Russian Federation, Hungary, Norway, Bulgaria, Slovakia

Search clinical trials for: NovoFine® vs Nucleus

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Slovenia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations